Avinger, Inc. (NASDAQ:AVGR) Short Interest Down 29.1% in January

Avinger, Inc. (NASDAQ:AVGR) saw a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 166,300 shares, a decrease of 29.1% from the December 31st total of 234,700 shares. Currently, 6.0% of the shares of the stock are sold short. Based on an average trading volume of 2,170,000 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Avinger in a report on Wednesday. They set a “hold” rating on the stock.

Avinger Price Performance

Shares of AVGR traded down $0.03 during trading hours on Friday, hitting $0.58. 303,114 shares of the company were exchanged, compared to its average volume of 903,613. Avinger has a one year low of $0.39 and a one year high of $5.45. The company has a market capitalization of $1.90 million, a PE ratio of -0.05 and a beta of 1.15. The firm has a fifty day simple moving average of $0.74 and a 200-day simple moving average of $0.97.

Avinger (NASDAQ:AVGR) last released its quarterly earnings data on Thursday, November 7th. The medical device company reported ($1.82) earnings per share for the quarter, beating the consensus estimate of ($2.03) by $0.21. Avinger had a negative net margin of 261.06% and a negative return on equity of 5,527.11%. The firm had revenue of $1.65 million for the quarter, compared to analyst estimates of $1.60 million. During the same quarter in the prior year, the business earned ($2.92) EPS. Sell-side analysts expect that Avinger will post -4.69 EPS for the current year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.